Conditions

TrialNet research reveals the benefits of Teplizumab in delaying clinical type 1 diabetes in people at high risk.

The PREVIEW study examined which lifestyle interventions make a difference in preventing prediabetes from progressing to type 2.

RISE study data on improvements of beta-cell function in type 2 diabetes found response to treatment differs in adults vs youth.

Which baseline characteristics in pregnant mothers predispose a higher risk of adverse neonatal events?

Specific antihypertensive treatment goals in high-risk patients are a widely controversial topic; which type of patient with diabetes benefits most from blood pressure lowering medications?

When should women with polycystic ovary syndrome (PCOS) be considered for type 2 diabetes screening?

Why patients with type 1 diabetes are more likely to spend time in hypoglycemia.

Obesity has  been a leading cause of mortality and morbidity of cardiovascular disease.

Can a patient with type 2 diabetes diagnosed with dementia have increased rate of mortality?

Which baseline clinical characteristics of patients with newly diagnosed diabetes lead us to providing more personalized care?